Vimarsana
Biggest News Aggregation in the World

Page 11 - Pharma Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Bio Today - Breaking & Trending Today

Nicox Announces Presentations of Additional NCX 470 Data at the Upcoming World Glaucoma Congress - Vimarsana News

Nicox Announces Presentations of Additional NCX 470 Data at the Upcoming World Glaucoma Congress

Press ReleaseNicox Announces Presentations of Additional NCX 470 Data at the Upcoming World Glaucoma CongressMarch 21, 2023 - release at 7:30 am CET Sophia Antipolis, FranceNicox SA (Euronext Paris: FR0013018124

Nicox to Present at Upcoming Scientific Conferences - Vimarsana News

Nicox to Present at Upcoming Scientific Conferences

Press ReleaseNicox to Present at Upcoming Scientific ConferencesMarch 3, 2023 – release at 7:30 am CET Sophia Antipolis, FranceNicox SA (Euronext Paris:...

Nicox: Ordinary Shareholder Meeting of February 28, 2023 - Approval of all Resolutions - Vimarsana News

Nicox: Ordinary Shareholder Meeting of February 28, 2023 - Approval of all Resolutions

Press ReleaseNicox: Ordinary Shareholder Meeting of February 28, 2023 - Approval of all ResolutionsMarch 1st, 2023 - release at 7:30 am CETSophia Antipolis, FranceNicox SA (Euronext Paris: FR0013018124

Pherecydes Pharma: ERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage Therapies - Vimarsana News

Pherecydes Pharma: ERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage Therapies

Conference call and webcast in English on February 16, 2023 at 8:30am EST 02:30pm CET and in French on the same day at 12pm EST 6pm CET Strategic combination would build on complementary expertise

Nicox Provides Fourth Quarter 2022 Financial Highlights - Vimarsana News

Nicox Provides Fourth Quarter 2022 Financial Highlights

Press ReleaseNicox Provides Fourth Quarter 2022 Financial Highlights Net revenue €1.0 million for fourth quarter 2022, and €3.3 million for the full year 2022; cash of €27.7 million on December